HomeScienceImpact of second-degree related donor on the outcomes of T cell-replete haploidentical...

Impact of second-degree related donor on the outcomes of T cell-replete haploidentical transplantation with post-transplant cyclophosphamide

[ad_1]

  • Luznik L, O’Donnell PV, Symons HJ, Chen AR, Leffell MS, Zahurak M, et al. HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. Biol Blood Marrow Transpl. 2008;14:641–50.

    CAS 
    Article 

    Google Scholar
     

  • Chang YJ, Huang XJ. Haploidentical bone marrow transplantation without T-cell depletion. Semin Oncol. 2012;39:653–6.

    Article 

    Google Scholar
     

  • Kasamon YL, Luznik L, Leffell MS, Kowalski J, Tsai H-L, Bolanos-Meade J, et al. Nonmyeloablative HLA-haploidentical bone marrow transplantation with high-dose posttransplantation cyclophosphamide: effect of HLA disparity on outcome. Biol Blood Marrow Transpl. 2010;16:482–9.

    CAS 
    Article 

    Google Scholar
     

  • Ciurea SO, Al Malki MM, Kongtim P, Fuchs EJ, Luznik L, Huang XJ, et al. The European Society for Blood and Marrow Transplantation (EBMT) consensusrecommendations for donor selection in haploidentical hematopoietic cell transplantation. Bone Marrow Transpl. 2020;55:12–24.

    CAS 
    Article 

    Google Scholar
     

  • Canaani J, Savani BN, Labopin M, Huang XJ, Ciceri F, Arcese W, et al. Impact of ABO incompatibility on patient outcome in haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia – a report from the acute leukemia working party of the EBMT. Haematologica. 2017;102:1066–74.

    CAS 
    Article 

    Google Scholar
     

  • Canaani J, Savani BN, Labopin M, Huang XJ, Ciceri F, Arcese W, et al. Donor age determines outcome in acute leukemia patients over 40 undergoing haploidentical hematopoietic cell transplantation. Am J Hematol. 2018;93:246–53.

    Article 

    Google Scholar
     

  • Mariotti J, Raiola AM, Evangelista A, Carella AM, Martino M, Patriarca F, et al. Impact of donor age and kinship on clinical outcomes after T-cell-replete haploidentical transplantation with PT-Cy. Blood Adv. 2020;4:3900–12.

    Article 

    Google Scholar
     

  • DeZern A, Franklin C, Tsai HL, Imus PH, Cooke KR, Varadhan R, et al. Relationship of donor age and relationship to outcomes of haploidentical transplantation with posttransplant cyclophosphamide. Blood Adv. 2021;5:1360–8.

    CAS 
    Article 

    Google Scholar
     

  • McCurdy SR, Kanakry JA, Showel MM, Tsai HL, Bolaños-Meade J, Rosner GL. Outcomes of Nonmyeloablative HLA-Haploidentical Blood or Marrow Transplantation with High-dose post-transplantation cyclophosphamide in older adults. Blood. 2015;125:3024–31.

    CAS 
    Article 

    Google Scholar
     

  • Solomon SR, Aubrey MT, Zhang X, Piluso A, Freed BM, Brown S, et al. Selecting the Best Donor for Haploidentical Transplant: Impact of HLA, Killer Cell Immunoglobulin-Like Receptor Genotyping, and Other Clinical Variables. Biol Blood Marrow Transpl. 2018;24:789–98.

    CAS 
    Article 

    Google Scholar
     

  • Bazarbachi A, Boumendil A, Finel H, Mohty M, Castagna L, Blaise D, et al. Influence of donor type, stem cell source and conditioning on outcomes after haploidentical transplant for lymphoma – a LWP-EBMT study. Br J Haematol. 2020;188:745–56.

    CAS 
    Article 

    Google Scholar
     

  • Garnier A, Guillaume T, Peterlin P, Bene MC, Le Bris Y, Dubruille V, et al. Second-degree relative donors for T-replete haploidentical allogeneic stem cell transplantation with high-dose post-transplant cyclophosphamide: toward crossing the major HLA barrier. Bone Marrow Transpl. 2017;52:1063–4.

    CAS 
    Article 

    Google Scholar
     

  • Elmariah H, Kasamon YL, Zahurak M, Macfarlane KW, Tucker N, Rosner GL, et al. Haploidentical bone marrow transplantation with post-transplant cyclophosphamide using non-first-degree related donors. Biol Blood Marrow Transpl. 2018;24:1099–102.

    Article 

    Google Scholar
     

  • Bacigalupo A, Ballen K, Rizzo D, Giralt S, Lazarus H, Ho V, et al. Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transpl. 2009;15:1628–33.

    Article 

    Google Scholar
     

  • Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transpl. 1995;15:825–8.

    CAS 

    Google Scholar
     

  • Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transpl. 2005;11:945–56.

    Article 

    Google Scholar
     

  • Holtan SG, DeFor TE, Lazaryan A, Bejanyan N, Aroa M, Brunstein CG, et al. Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation. Blood 2015;125:1333–8.

    CAS 
    Article 

    Google Scholar
     

  • Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457–81.

    Article 

    Google Scholar
     

  • Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med. 1999;18:695–706.

    CAS 
    Article 

    Google Scholar
     

  • Fine J, Gray R. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94:496–7.

    Article 

    Google Scholar
     

  • Zhang YY, Liu DH, Liu KY, Xu L-P, Chen H, Han W, et al. HLA-haploidentical hematopoietic SCT from collateral related donors without in vitro T-cell depletion for hematological malignancies. Bone Marrow Transpl. 2014;49:496–501.

    Article 

    Google Scholar
     

  • Mo XD, Zhang YY, Zhang XH, Xu L-P, Wang Y, Yan C-H, et al. The role of collateral related donors in haploidentical hematopoietic stem cell transplantation. Sci Bull. 2018;63:1376–82.

    Article 

    Google Scholar
     

  • Chang YJ, Luznik L, Fuchs EJ, Huang XJ. How do we choose the best donor for T-cell-replete, HLA-haploidentical transplantation? J Hematol Oncol. 2016;9:35.

    Article 

    Google Scholar
     

  • McCurdy SR, Luznik L. How we perform haploidentical stem cell transplantation with posttransplant cyclophosphamide. Hematol Am Soc Hematol Educ Program. 2019;2019:513–21.

    Article 

    Google Scholar
     

  • McCurdy SR, Zhang MJ, St Martin A, Al Malki MM, Bashey A, Gaballa S, et al. Effect of donor charac- teristics on haploidentical transplantation with post-transplantation cy- clophosphamide. Blood Adv. 2018;2:299–307.

    CAS 
    Article 

    Google Scholar
     


  • [ad_2]

    Source link

    RELATED ARTICLES

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here

    Most Popular

    Recent Comments

    %d bloggers like this: